Our Services

A CDMO supports a drug product across its lifecycle by providing integrated development, analytical, manufacturing, and packaging services from early formulation through commercial supply. At Groupe PARIMA, we support this progression through a unified service model that ensures technical continuity, process control, and regulatory alignment as products move from development into clinical and commercial manufacturing.

A pharmaceutical CDMO should provide in‑house analytical method development, method validation, release testing, and stability studies to support regulatory compliance and product control. Groupe PARIMA delivers fully integrated analytical services that support formulation development, manufacturing control, and regulatory submissions throughout the product lifecycle.

Pharmaceutical product development includes pre‑formulation studies, formulation development, process optimization, scale‑up, and process validation. At Groupe PARIMA, product development is designed to build robust, scalable formulations supported by strong analytical understanding and manufacturing readiness.

A CDMO typically offers GMP drug manufacturing, clinical supply, primary and secondary packaging, labeling, and serialization services. Groupe PARIMA provides end‑to‑end manufacturing and packaging services for non‑sterile drug products, ensuring consistent quality, regulatory alignment, and reliable supply from clinical to commercial scale.